Literature DB >> 23766334

Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort.

Alvar Agusti1, Lisa D Edwards, Bartolomé Celli, William Macnee, Peter M A Calverley, Hana Müllerova, David A Lomas, Emiel Wouters, Per Bakke, Steve Rennard, Courtney Crim, Bruce E Miller, Harvey O Coxson, Julie C Yates, Ruth Tal-Singer, Jørgen Vestbo.   

Abstract

The 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) classifies patients with chronic obstructive pulmonary disease (COPD) into four groups (A to D). We explored the characteristics, stability and relationship to outcomes of these groups within the ECLIPSE study (Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points) (n = 2101). Main results showed that: 1) these groups differed in several clinical, functional, imaging and biological characteristics in addition to those used for their own definition; 2) A and D groups were relatively stable over time, whereas groups B and C showed more temporal variability; 3) the risk of exacerbation over 3 years increased progressively from A to D, whereas that of hospitalisation and mortality were lowest in A, highest in D and intermediate and similar in B and C, despite the former having milder airflow limitation. The prevalence of comorbidities and persistent systemic inflammation were highest in group B. The different longitudinal behaviour of group A versus B and C versus D (each pair with similar forced expiratory volume in1 s (FEV1) values supports the 2011 GOLD proposal of assessing COPD patients by more than FEV1 only. However the assumption that symptoms do not equate to risk appears to be naïve, as groups B and C carry equally poor clinical outcomes, though for different reasons.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23766334     DOI: 10.1183/09031936.00195212

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  72 in total

Review 1.  Updates in Chronic Obstructive Pulmonary Disease for the Year 2014.

Authors:  Sibel Atış Naycı; Lütfi Çöplü; Alev Gürgün; Nurdan Köktürk; Mehmet Polatlı; Elif Şen; Sema Umut; Esra Uzaslan; Nurhayat Yıldırım; Peter J Barnes
Journal:  Turk Thorac J       Date:  2015-04-01

2.  Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.

Authors:  Prescott G Woodruff; R Graham Barr; Eugene Bleecker; Stephanie A Christenson; David Couper; Jeffrey L Curtis; Natalia A Gouskova; Nadia N Hansel; Eric A Hoffman; Richard E Kanner; Eric Kleerup; Stephen C Lazarus; Fernando J Martinez; Robert Paine; Stephen Rennard; Donald P Tashkin; MeiLan K Han
Journal:  N Engl J Med       Date:  2016-05-12       Impact factor: 91.245

3.  Adherence and healthcare utilization among older adults with COPD and depression.

Authors:  Jennifer S Albrecht; Bilal Khokhar; Ting-Ying Huang; Yu-Jung Wei; Ilene Harris; Patience Moyo; Peter Hur; Susan W Lehmann; Giora Netzer; Linda Simoni-Wastila
Journal:  Respir Med       Date:  2017-06-03       Impact factor: 3.415

4.  Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group.

Authors:  Michael T Durheim; Patrick J Smith; Michael A Babyak; Stephanie K Mabe; Tereza Martinu; Karen E Welty-Wolf; Charles F Emery; Scott M Palmer; James A Blumenthal
Journal:  Ann Am Thorac Soc       Date:  2015-03

5.  The effects of a telehealth coping skills intervention on outcomes in chronic obstructive pulmonary disease: primary results from the INSPIRE-II study.

Authors:  James A Blumenthal; Charles F Emery; Patrick J Smith; Francis J Keefe; Karen Welty-Wolf; Stephanie Mabe; Tereza Martinu; Julie J Johnson; Michael A Babyak; Virginia F O'Hayer; Philip T Diaz; Michael Durheim; Donald Baucom; Scott M Palmer
Journal:  Psychosom Med       Date:  2014-10       Impact factor: 4.312

6.  The 2014 Updated GOLD Strategy: A Comparison of the Various Scenarios.

Authors:  Sarah Wilke; Dionne E Smid; Martijn A Spruit; Daisy J A Janssen; Jean W M Muris; Thys van der Molen; Marjan van den Akker; Paul W Jones; Emiel F M Wouters; Frits M E Franssen
Journal:  Chronic Obstr Pulm Dis       Date:  2014-09-25

7.  Biobehavioral Prognostic Factors in Chronic Obstructive Pulmonary Disease: Results From the INSPIRE-II Trial.

Authors:  James A Blumenthal; Patrick J Smith; Michael Durheim; Stephanie Mabe; Charles F Emery; Tereza Martinu; Philip T Diaz; Michael Babyak; Karen Welty-Wolf; Scott Palmer
Journal:  Psychosom Med       Date:  2016 Feb-Mar       Impact factor: 4.312

8.  Prognostic Accuracy of Three COPD Classification Systems in Relation to Long-Term Mortality of COPD Patients: A Prospective Multicenter Study.

Authors:  Marek Plutinsky; Kristian Brat; Michal Svoboda; Jaromir Zatloukal; Patrice Popelkova; Vladimir Koblizek
Journal:  Lung       Date:  2019-01-29       Impact factor: 2.584

9.  Quantitative Imaging Markers of Lung Function in a Smoking Population Distinguish COPD Subgroups with Differential Lung Cancer Risk.

Authors:  Christine M Lusk; Angela S Wenzlaff; Donovan Watza; Jessica C Sieren; Natasha Robinette; Garrett Walworth; Michael Petrich; Christine Neslund-Dudas; Michael J Flynn; Thomas Song; David Spizarny; Michael J Simoff; Ayman O Soubani; Shirish Gadgeel; Ann G Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-14       Impact factor: 4.254

10.  Analysis of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome Defined on the Basis of Bronchodilator Response and Degree of Emphysema.

Authors:  James Cosentino; Huaqing Zhao; Megan Hardin; Craig P Hersh; James Crapo; Victor Kim; Gerard J Criner
Journal:  Ann Am Thorac Soc       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.